Atlantic Health System
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Atlantic Health System sits in the top decile of US sponsors by registered trial count (#415 of 15,742 sponsors by registered trial count).
Atlantic Health System: 43 sponsored US clinical trials, 7 recruiting.
Atlantic Health System sponsors 43 registered US clinical trials on ClinicalTrials.gov, 7 of them currently recruiting, and 24 completed. 4 of these trials are in Phase 3-4 (later-stage) and 5 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Urethral Bulking, with 1 trials.
Top-decile sponsor footprint
Atlantic Health System ranks in the top decile of sponsors by registered trial count (#415 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
24 of 33 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (72.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
43 total, page 1 of 1
Silodosin for Urinary Symptoms in Female Patients With Multiple Sclerosis
NCT07614321
Pre-Emptive LAVA-ECMO for Complex High-Risk TAVR
NCT07309029
Is Methenamine Prophylaxis for Urinary Tract Infection After Midurethral Sling as Effective as Antibiotic Prophylaxis?
NCT06810687
Assessing the Relationship Between Symptoms and Mitral Regurgitnant. Severity
NCT06738615
Atlantic Lipid Lowering Treatment Optimization Program
NCT06439654
The Effectiveness of Prophylactic Antibiotics for Urethral Bulking
NCT06261736
Use of Prophylactic Antibiotics Prior to OnabotulinumtoxinA
NCT05519072
Implementation of Vancomycin Powder Application in the Emergency Department for Open Fractures
NCT07659886
In-Clinic Assessment of Vaginal Mucosal Safety Following Repetitive Use of the Livi Device
NCT07445958
A Novel Method for Determination of Thromboembolic Stroke Origin
NCT06961604
Evaluation of a Postcoital Sponge on Self-Reported Vaginal Health Parameters
NCT06530186
Absorbable Suture vs Permanent Suture in Sacrospinous Ligament Suspension
NCT05688059
"The Efficacy of Exparel Versus a Multidrug Cocktail in Soft Tissue Tumors"
NCT05355597
Nurses Caring for Patients With Covid-19
NCT06012539
CO2 Laser vs Lidocaine for Vestibulodynia in Premenopausal Women
NCT05336825
Lidocaine for Pain After Urodynamic Testing
NCT03390790
A Trial of Yoga in Pediatric Inflammatory Bowel Disease
NCT03338894
Liposomal Bupivacaine vs. Bupivacaine Hydrochloride and Lidocaine During Suburethral Sling Placement
NCT02875015
Indwelling vs Immediate Removal of Foley Catheter After Robotic Assisted Laparoscopic Sacrocolpopexy: a Prospective Study
NCT02765893
Mobile Health Monitoring Solution for Heart Failure Patients
NCT02594007
Comparison of 2 Lightweight Y-meshes After Laparoscopic Sacrocolpopexy
NCT02248935
Non-inferiority Study Comparing daVinci Skills Simulator to Mimic dV-Trainer for Preparing Residents to Perform Live Human Surgery
NCT02267551
Single Incision Suburethral Sling at Time of Robotic Sacrocolpopexy
NCT01982188
5-Year Objective and Subjective Results of a Mid-Urethral Sling
NCT01657916
Do Patients With Early Post Operative Recurrence of Pelvic Organ Prolapse Have a Genetic Predisposition?
NCT01614587
Exhaled Nitric Oxide and Airway Caliber in Children With Asthma
NCT01645397
Validation Study for Robotic Surgery Simulator
NCT01618994
Uphold Versus Robotic Surgery for Pelvic Prolapse Repair: A Decision Analytic Approach
NCT01611285
A Study of Robotic Assisted Laparoscopic Sacral Colpopexy Using Alyte Mesh
NCT01320644
Male Sexual Experience and Its Impact on Quality of Life Before and After Their Sexual Partners Undergo Polypropylene Mesh Augmented Pelvic Floor Reconstruction
NCT01320631
One Year Outcome After Robotic Assisted Laparoscopic Sacral Colpopexy, a Case Series Review
NCT01055860
Evaluation of the Avaulta Procedure for the Correction of Pelvic Organ Prolapse - Results at 1 Year
NCT00774215
High-Dose Erythropoietin in Extremely Premature Infants to Prevent/Attenuate Brain Injury: A Phase II Study
NCT00589953
Cohort Study of Bowel Function Following Robotic-assisted Laparoscopic Sacrocolpopexy
NCT01618292
Smoking Cessation Program: A Quality Improvement Trial in a Resident-Based Outpatient Clinic
NCT00436943
Randomized Controlled Trial Comparing Traditional Pelvic Floor Rehabilitation to Pilates in Increasing Pelvic Muscles Strength.
NCT00549458
Randomized Controlled Trial Comparing Acellular Collagen Biomesh (Pelvisoft) to Polypropylene Mesh(Pelvitex) for Sacral Colpopexy
NCT00564083
Evaluation of Obstructive Sleep Apnea as a Risk Factor for Pulmonary Embolism
NCT00409045
Evaluation of an ICU Hyperglycemia Protocol Using Insulin Aspart
NCT00206206
Prediction of Weaning Outcomes by Using Rate of Change of Rapid Shallow Breathing Index
NCT00366197
Safety Study: Combined Modality Treatment for Non-Small Cell Lung Cancer
NCT00265603
Brain Oxygenation Monitoring in Patients Undergoing Coronary Artery Bypass Surgery
NCT00137527
Feasibility Study of Photopheresis Post Angioplasty
NCT00157001
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
| Phase 2 | 3 |
| Phase 3 | 1 |
| Phase 4 | 3 |
Therapeutic Areas
What is open in the Atlantic Health System pipeline
7 recruiting of 43 indexed (16% open); 24 completed (56%).
Phase mix: 4 late (III/IV) vs 5 early (I/II) (balanced across stages).
Top condition: Urethral Bulking (1 trial), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Atlantic Health System: open-pipeline peers nationwide
Peers matched on 43 registered trials and 16% open enrollment, not the therapeutic-area sidebar.
Atlantic Health System sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 43 trials (± recruiting share)
- Cumberland Pharmaceuticals · 43 trials · 2% recruiting
- Lahey Clinic · 43 trials · 9% recruiting
- Octapharma · 43 trials · 21% recruiting
- Seattle Institute for Biomedical and Clinical Research · 43 trials · 14% recruiting
Sponsors near 16% open enrollment (± trial volume)
- Drexel University · 16% recruiting · 92 trials
- BioMarin Pharmaceutical · 16% recruiting · 80 trials
- Case Western Reserve University · 16% recruiting · 141 trials
- H. Lee Moffitt Cancer Center and Research Institute · 16% recruiting · 502 trials
Related
What to do with this Atlantic Health System page
43 registered trials is a research-attention snapshot, not an endorsement of Atlantic Health System or any single study.
- 7 of Atlantic Health System's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Urethral Bulking is the condition Atlantic Health System studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Urethral Bulking trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Atlantic Health System pipeline card: 43 registered trials from official public datasets.Report a data error.